| NTP ICE endocrine |
AC50 |
0.33676788105873 |
uM |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=9958; RecordID=ERPathway2016_156; DatasetName=ERPathway2016; DTXSID=DTXSID5022308; Assay=ER Pathway Model, Antagonist; Endpoint=AC50; Response=0.33676788105873; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
84500 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=128; Record_ID=endocrine_invitro_122; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=84500; Reported_Response_Unit=nM; Response=84500; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Fang et al. 2003; 14565775; 10.1021/tx030011g; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
100000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=131; Record_ID=endocrine_invitro_125; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=100000; Reported_Response_Unit=nM; Response=100000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Pfitscher et al. 2008; 18809497; 10.1016/j.jsbmb.2008.08.007; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
3.7 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=191; Record_ID=endocrine_invitro_185; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=1000; Reported_Response_Unit=ng/L; Conversion_Factor=Molecular Weight; Conversion_Factor_Value=270.24; Conversion_Factor_Source=EPA Dashboard; Converted_Response=3.7004144464179989; Converted_Response_Unit=nM; Response=3.7; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
140000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=232; Record_ID=endocrine_invitro_226; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=140000; Reported_Response_Unit=nM; Response=140000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Freyberger and Ahr 2004; 14751668; 10.1016/j.tox.2003.09.008; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
155000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=233; Record_ID=endocrine_invitro_227; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=155000; Reported_Response_Unit=nM; Response=155000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Freyberger and Ahr 2004; 14751668; 10.1016/j.tox.2003.09.008; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
270000 |
nM |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=478; Record_ID=endocrine_invitro_472; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=AC50/EC50/IC50; Reported_Response=270000; Reported_Response_Unit=nM; Response=270000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Ichige et al. 2013; 23402539; 10.1021/jf305233t; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
239.9 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=7847; Record_ID=endocrine_invitro_3468; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Agonist; Endpoint=AC50/EC50/IC50; Reported_Response=239.88329189999999; Reported_Response_Unit=nM; Response=239.9; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Bartonkova et al. 2015; 25811655; 10.1371/journal.pone.0121316; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
162.2 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=7848; Record_ID=endocrine_invitro_3469; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Agonist; Endpoint=AC50/EC50/IC50; Reported_Response=162.1810097; Reported_Response_Unit=nM; Response=162.2; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Bartonkova et al. 2015; 25811655; 10.1371/journal.pone.0121316; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
AC50/EC50/IC50 |
1300000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=13274; Record_ID=endocrine_invitro_4113; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Antagonist; Endpoint=AC50/EC50/IC50; Reported_Response=1300000; Reported_Response_Unit=nM; Response=1300000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
ACC |
0.0615586769783145 |
uM |
- |
- |
- |
ERPathway2016; ER Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=9959; RecordID=ERPathway2016_156; DatasetName=ERPathway2016; DTXSID=DTXSID5022308; Assay=ER Pathway Model, Antagonist; Endpoint=ACC; Response=0.0615586769783145; Response_Unit=uM; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
EC50 |
271 |
nM |
- |
- |
- |
In Vitro; ER Transactivation-Agonist (VM7Luc Assay) |
sheet=Data_invitro; excel_row=16617; Record_ID=endocrine_invitro_4456; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=ER Transactivation-Agonist (VM7Luc Assay); Endpoint=EC50; Reported_Response=2.7099999999999998E-7; Reported_Response_Unit=M; Conversion_Factor=1000000000; Conversion_Factor_Value=1000000000; Converted_Response=270.99999999999903; Converted_Response_Unit=nM; Response=271; Response_Unit=nM; Reference=|OECD TG 455; https://www.oecd.org/env/test-no-455-performance-based-test-guideline-for-stably-transfected-transactivation-in-vitro-assays-to-detect-estrogen-receptor-9789264265295-en.htm; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LEL |
10000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=10384; Record_ID=endocrine_invitro_3665; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Agonist; Endpoint=LEL; Reported_Response=10000; Reported_Response_Unit=nM; Response=10000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Stroheker et al. 2004; 15110097; 10.1016/j.fct.2004.01.012; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LEL |
500 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Agonist |
sheet=Data_invitro; excel_row=10847; Record_ID=endocrine_invitro_3655; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Agonist; Endpoint=LEL; Reported_Response=500; Reported_Response_Unit=nM; Response=500; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LEL |
1 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=14871; Record_ID=endocrine_invitro_4243; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=1; Reported_Response_Unit=nM; Response=1; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Stroheker et al. 2004; 15110097; 10.1016/j.fct.2004.01.012; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LEL |
10 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=15018; Record_ID=endocrine_invitro_4254; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=10; Reported_Response_Unit=nM; Response=10; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LEL |
100000 |
nM |
- |
- |
- |
In Vitro; AR Transactivation-Antagonist |
sheet=Data_invitro; excel_row=15043; Record_ID=endocrine_invitro_4238; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Transactivation-Antagonist; Endpoint=LEL; Reported_Response=100000; Reported_Response_Unit=nM; Response=100000; Response_Unit=nM; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Gao et al. 2004; 15042621; 10.1002/pros.10375; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
20 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=819; Record_ID=endocrine_invivo_132; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=20; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=20; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Yamasaki et al. 2002; 12415423; 10.1007/s00204-002-0383-1|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
100 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=4 days; Age_at_First_Dose=PND 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=820; Record_ID=endocrine_invivo_127; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=100; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Wistar; Strain=Wistar; Sex=Female; Route=Oral; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Stroheker et al. 2003; 12849853; 10.1016/s0890-6238(03)00044-3|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
15 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=821; Record_ID=endocrine_invivo_135; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=15; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
10 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=825; Record_ID=endocrine_invivo_145; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=10; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=10; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 6; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
60 |
mg/kg bw/day |
Rat |
Oral |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=828; Record_ID=endocrine_invivo_118; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=60; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Oral; Maximum_Dose=300; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol D; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
2.5 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=5 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=830; Record_ID=endocrine_invivo_120; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=2.5; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=10; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 2; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
200 |
mg/kg bw/day |
Mouse |
Oral |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=2 weeks; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=831; Record_ID=endocrine_invivo_122; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=200; Response_Unit=mg/kg/day; Species=Mouse; Reported_Strain=C57BL/6J; Strain=C57BL/6; Sex=Female (ovariectomized); Route=Oral; Maximum_Dose=600; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Ohta et al. 2012; 23037998; 10.2131/jts.37.879|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
1 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=838; Record_ID=endocrine_invivo_128; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=1; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
5 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=842; Record_ID=endocrine_invivo_131; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=5; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=20; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Yamasaki et al. 2002; 12415423; 10.1007/s00204-002-0383-1|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
LOEL |
35 |
mg/kg bw/day |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=847; Record_ID=endocrine_invivo_136; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=LOEL; Response=35; Response_Unit=mg/kg/day; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=50; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Model Score |
0 |
unitless |
- |
- |
- |
ARPathway2016; AR Pathway Model, Antagonist |
sheet=Integrated_approaches; excel_row=9954; RecordID=ARPathway2016_1213; DatasetName=ARPathway2016; DTXSID=DTXSID5022308; Assay=AR Pathway Model, Antagonist; Endpoint=Model Score; Response=0; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Model Score |
0.538 |
unitless |
- |
- |
- |
ERPathway2016; ER Pathway Model, Agonist |
sheet=Integrated_approaches; excel_row=9960; RecordID=ERPathway2016_156; DatasetName=ERPathway2016; DTXSID=DTXSID5022308; Assay=ER Pathway Model, Agonist; Endpoint=Model Score; Response=0.538; Response_Unit=Unitless; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
PC50 |
24.5 |
nM |
- |
- |
- |
In Vitro; ER Transactivation-Agonist (STTA Assay) |
sheet=Data_invitro; excel_row=16526; Record_ID=endocrine_invitro_4456; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=ER Transactivation-Agonist (STTA Assay); Endpoint=PC50; Reported_Response=2.4500000000000001E-8; Reported_Response_Unit=M; Conversion_Factor=1000000000; Conversion_Factor_Value=1000000000; Converted_Response=24.5; Converted_Response_Unit=nM; Response=24.5; Response_Unit=nM; Reference=|OECD TG 455; https://www.oecd.org/env/test-no-455-performance-based-test-guideline-for-stably-transfected-transactivation-in-vitro-assays-to-detect-estrogen-receptor-9789264265295-en.htm; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
RBA |
0.003631 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=1896; Record_ID=endocrine_invitro_655; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=RBA; Reported_Response=-2.44; Reported_Response_Unit=Unitless; Conversion_Factor=Anti-log; Converted_Response=3.630780547701011E-3; Converted_Response_Unit=Unitless; Response=0.003631; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Hong et al. 2003; 14758981; 10.1080/10629360310001623962; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
RBA |
0.0039 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2075; Record_ID=endocrine_invitro_226; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=RBA; Reported_Response=3.8999999999999998E-3; Reported_Response_Unit=Unitless; Response=0.0039; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Freyberger and Ahr 2004; 14751668; 10.1016/j.tox.2003.09.008; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
RBA |
0.0029 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2076; Record_ID=endocrine_invitro_227; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=RBA; Reported_Response=2.8999999999999998E-3; Reported_Response_Unit=Unitless; Response=0.0029; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Freyberger and Ahr 2004; 14751668; 10.1016/j.tox.2003.09.008; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
RBA |
0.0036 |
unitless |
- |
- |
- |
In Vitro; AR Binding |
sheet=Data_invitro; excel_row=2077; Record_ID=endocrine_invitro_122; Data_Type=In Vitro; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=AR Binding; Endpoint=RBA; Reported_Response=3.5999999999999999E-3; Reported_Response_Unit=Unitless; Response=0.0036; Response_Unit=Unitless; Reference=Kleinstreuer et al. 2016; 27933809; 10.1021/acs.chemrestox.6b00347|Fang et al. 2003; 14565775; 10.1021/tx030011g; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
200 |
% |
Rat |
Oral |
Treatment_Duration=4 days; Age_at_First_Dose=PND 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=466; Record_ID=endocrine_invivo_127; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=200; Response_Unit=%; Species=Rat; Reported_Strain=Wistar; Strain=Wistar; Sex=Female; Route=Oral; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Stroheker et al. 2003; 12849853; 10.1016/s0890-6238(03)00044-3|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
179 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=468; Record_ID=endocrine_invivo_130; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=179; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
250 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=469; Record_ID=endocrine_invivo_132; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=250; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=20; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Yamasaki et al. 2002; 12415423; 10.1007/s00204-002-0383-1|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
153 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=471; Record_ID=endocrine_invivo_135; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=153; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
157 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=473; Record_ID=endocrine_invivo_137; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=157; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
210 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=4 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=476; Record_ID=endocrine_invivo_140; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=210; Response_Unit=%; Species=Rat; Reported_Strain=SD; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=750; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Zhang et al. 2008; 19239007; Not available|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
167 |
% |
Rat |
Subcutaneous |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=477; Record_ID=endocrine_invivo_142; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=167; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol D; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
180 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=2 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=478; Record_ID=endocrine_invivo_145; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=180; Response_Unit=%; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=10; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 6; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
136 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=480; Record_ID=endocrine_invivo_117; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=136; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=500; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
183 |
% |
Rat |
Oral |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=481; Record_ID=endocrine_invivo_118; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=183; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Oral; Maximum_Dose=300; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol D; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
120 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=5 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=483; Record_ID=endocrine_invivo_120; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=120; Response_Unit=%; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=10; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 2; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
260 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=485; Record_ID=endocrine_invivo_123; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=260; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=20; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Yamasaki et al. 2002; 12415423; 10.1007/s00204-002-0383-1|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
148 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=487; Record_ID=endocrine_invivo_125; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=148; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=50; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
118 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=491; Record_ID=endocrine_invivo_128; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=118; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol B; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
230 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=495; Record_ID=endocrine_invivo_131; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=230; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=20.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
245 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 20 to 22; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=497; Record_ID=endocrine_invivo_133; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=245; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD); Strain=Sprague-Dawley; Sex=Female; Route=Subcutaneous; Maximum_Dose=200; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Estradiol; Reference=Yamasaki et al. 2002; 11750080; 10.1016/s0300-483x(01)00505-4|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
249 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=502; Record_ID=endocrine_invivo_134; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=249; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=300.0; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
156 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=506; Record_ID=endocrine_invivo_136; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=156; Response_Unit=%; Species=Rat; Reported_Strain=Crl:CD(SD)IGS BR; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=50; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol C; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
161 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=509; Record_ID=endocrine_invivo_138; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=161; Response_Unit=%; Species=Rat; Reported_Strain=Alpk:ApfSD; Strain=Alderley Park; Sex=Female; Route=Oral; Maximum_Dose=500; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
240 |
% |
Rat |
Subcutaneous |
Treatment_Duration=3 days; Age_at_First_Dose=PND 19 to 20; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3 |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=511; Record_ID=endocrine_invivo_139; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=240; Response_Unit=%; Species=Rat; Reported_Strain=Ap; Strain=Alderley Park; Sex=Female; Route=Subcutaneous; Maximum_Dose=50; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Experiment 1; Reference=Tinwell and Ashby 2004; 15064164; 10.1289/ehp.6831|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
206 |
% |
Rat |
Subcutaneous |
Treatment_Duration=7 days; Age_at_First_Dose=PND 56 to 84; Age_Ovariectomized_or_Castrated=6 weeks; Time_Elapsed_Between_Surgery_and_Treatment=14 to 28 days; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=514; Record_ID=endocrine_invivo_141; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=206; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female (ovariectomized); Route=Subcutaneous; Maximum_Dose=80; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol D; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |
| NTP ICE endocrine |
Uterine weight increase vs control |
142 |
% |
Rat |
Oral |
Treatment_Duration=3 days; Age_at_First_Dose=PND 18; Time_Elapsed_Between_Last_Dose_and_Necropsy=24 hours; Number_of_Doses_Tested=3+ |
In Vivo; Uterotrophic-Agonist |
sheet=Data_invivo; excel_row=519; Record_ID=endocrine_invivo_144; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID5022308; Assay=Uterotrophic-Agonist; Endpoint=Uterine weight increase vs control; Response=142; Response_Unit=%; Species=Rat; Reported_Strain=Crj:CD(SD)IGS; Strain=Sprague-Dawley; Sex=Female; Route=Oral; Maximum_Dose=500; Maximum_Dose_Units=mg/kg/day; Reference_Hormone=Ethinylestradiol; Additional_Information=Protocol A; Reference=Kanno et al. 2003; 12948896; 10.1289/ehp.5780|Kleinstreuer et al. 2016; 26431337; 10.1289/ehp.1510183; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022308; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID5022308 |